Can I Take Ashwagandha with Lisinopril?

What Kind of Interaction Exists Between Ashwagandha and Lisinopril?

The interaction is pharmacodynamic, not pharmacokinetic. Lisinopril is renally cleared without significant CYP450 metabolism, so ashwagandha's withanolide compounds are unlikely to change how much lisinopril reaches systemic circulation or how quickly it is removed. The real concern is that both substances lower blood pressure through mechanistically distinct routes, and those effects add together.

Lisinopril blocks angiotensin-converting enzyme, cutting production of angiotensin II and reducing aldosterone release. Ashwagandha (Withania somnifera) appears to lower blood pressure partly through nitric-oxide-dependent vasodilation and partly through stress-axis suppression. When you stack two blood-pressure-lowering agents without adjusting the prescription dose, the combined drop may overshoot the therapeutic target.

Pharmacokinetic Profile of Lisinopril

Lisinopril is absorbed orally at roughly 25% bioavailability, peaks at 6 to 8 hours, and is excreted unchanged by the kidneys, with a half-life of approximately 12 hours [1]. Because it bypasses hepatic phase I and phase II metabolism almost entirely, herbal CYP3A4 or P-glycoprotein interactions do not apply here. This is actually reassuring: the interaction risk is easier to predict because it is purely about the blood pressure response, not about altered drug exposure.

Pharmacodynamic Profile of Ashwagandha on Blood Pressure

A 2019 randomized, double-blind, placebo-controlled trial (N=60) published in Medicine found that 240 mg/day of a standardized ashwagandha extract reduced systolic blood pressure by 6.2 mmHg and diastolic blood pressure by 3.2 mmHg versus placebo after 60 days [2]. A separate 8-week RCT (N=80) testing 300 mg twice daily of KSM-66 ashwagandha root extract recorded similar directional effects alongside reductions in perceived stress scores [3]. Neither of these trials enrolled patients already on antihypertensive drugs. That matters, because the starting blood pressure in drug-naive adults is higher, so the same absolute drop is proportionally less dangerous than it would be in someone whose pressure is already well controlled at, say, 118/74 mmHg on lisinopril 10 mg.

How Does Ashwagandha Affect Cortisol, and Why Does That Matter for Lisinopril Users?

Cortisol raises blood pressure through multiple pathways: it increases sodium retention, sensitizes vascular smooth muscle to catecholamines, and suppresses the vasodilatory prostaglandin system. Lisinopril counters one arm of this by reducing angiotensin II. When ashwagandha simultaneously blunts cortisol output, the net pressure effect depends on how dominant each mechanism is in a given patient.

A 60-day, double-blind RCT (N=64) in the Indian Journal of Psychological Medicine showed that 300 mg of ashwagandha root extract twice daily reduced serum cortisol by 27.9% compared with 7.9% in the placebo group (P<0.0001) [4]. Patients who are volume-sensitive hypertensives on lisinopril could see amplified antihypertensive effects if cortisol drops substantially, because cortisol-driven sodium retention was one of the factors keeping their pressure up.

What Cortisol Reduction Means Clinically

A 27.9% cortisol reduction sounds impressive, but morning cortisol normally sits between 6 to 23 mcg/dL in adults. Moving from 18 mcg/dL to 13 mcg/dL matters very differently for a patient whose lisinopril dose was recently up-titrated versus a stable patient on the same dose for two years. The stress-response axis interacts with blood pressure in a state-dependent way, so there is no universal answer to how much pressure will shift.

Who Is Most at Risk for Cortisol-Mediated Hypotension?

Patients at highest risk include those with chronic kidney disease (CKD) stages 3 or 4 already on lisinopril for renoprotection, people on diuretic combination regimens (for example lisinopril-hydrochlorothiazide), and older adults with reduced baroreceptor sensitivity. The 2023 ACC/AHA Hypertension Guideline explicitly notes that older patients are disproportionately vulnerable to orthostatic hypotension from additive antihypertensive agents [5].

Ashwagandha's Effect on Thyroid Hormones and Cardiovascular Regulation

This is the interaction that most clinicians overlook, and it may be the one with the most clinical weight for certain patients.

A 2019 pilot RCT (N=50) published in the Journal of Alternative and Complementary Medicine found that 600 mg/day of ashwagandha root extract for 8 weeks produced statistically significant increases in serum T3 (by 41.5 pg/mL), T4 (by 19.6 ng/dL), and a corresponding fall in TSH (by 1.8 mIU/L) compared with placebo [6]. All participants had subclinical hypothyroidism, so the baseline TSH was elevated. The direction of effect, however, is the key data point: ashwagandha pushes thyroid function toward a more active state.

Why Elevated Thyroid Hormones Complicate Hypertension Management

Excess thyroid hormone increases heart rate, cardiac output, and systolic blood pressure through direct beta-adrenergic-like effects on the myocardium and peripheral vasculature. Lisinopril targets the renin-angiotensin-aldosterone system (RAAS), not the adrenergic axis. A patient whose blood pressure was stable on lisinopril 20 mg could see systolic pressure climb 5 to 10 mmHg if ashwagandha sufficiently elevates free T4, because the mechanism driving the new pressure elevation is outside lisinopril's therapeutic scope.

Patients with Pre-Existing Thyroid Conditions

Patients already on levothyroxine should be especially cautious. Stacking ashwagandha's thyroid-stimulating effect onto a fixed levothyroxine dose creates two unpredictable variables at once. Any patient taking lisinopril alongside thyroid medication who wants to add ashwagandha should have TSH, free T3, and free T4 checked at baseline and at 8 weeks. This monitoring schedule aligns with the American Thyroid Association's guidance on re-checking thyroid panels 6 to 8 weeks after any change in thyroid-modulating therapy [7].

Does Ashwagandha Raise or Lower Potassium Levels?

Lisinopril inhibits aldosterone, which means it reduces renal potassium excretion. The drug's package insert lists hyperkalemia as a recognized adverse effect, particularly in patients with CKD or diabetes [8]. Ashwagandha has not been shown in controlled trials to directly alter serum potassium. No published pharmacological mechanism suggests that withanolides modulate renal tubular potassium handling. So this is not a documented interaction, but the background risk of hyperkalemia from lisinopril still applies and should not be forgotten when reviewing a patient's electrolyte panel.

Is the Combination Contraindicated? A Risk-Stratified View

Short answer: no formal contraindication exists in FDA labeling or in the Natural Medicines database's highest-tier evidence category. The interaction is rated "moderate" based on pharmacodynamic plausibility and the clinical trial data showing blood-pressure effects from ashwagandha. "Moderate" in Natural Medicines terminology means the combination warrants monitoring, not automatic avoidance [9].

The HealthRX medical team uses the following risk-stratification approach for patients asking about ashwagandha co-administration with lisinopril:

Low-complexity patients (generally acceptable with monitoring)

• Blood pressure well controlled on lisinopril monotherapy (below 130/80 mmHg per most recent reading)
• No CKD, no diabetes, no thyroid disease
• Not on potassium-sparing diuretics or NSAIDs
• Able to check blood pressure at home twice daily

Intermediate-complexity patients (proceed only with prescriber approval and baseline labs)

• CKD stage 2 to 3, or diabetes with microalbuminuria
• Subclinical hypothyroidism or borderline TSH
• On combination antihypertensive regimens (for example lisinopril plus amlodipine)
• Age 65 or older

High-complexity patients (avoid without specialist review)

• CKD stage 4 to 5 or on dialysis
• Active heart failure requiring tight fluid balance
• Overt hypothyroidism or hyperthyroidism on active treatment
• Recent up-titration of lisinopril dose within the past 4 weeks

What Does the Evidence Say About Ashwagandha Safety in General?

A 2021 systematic review of ashwagandha safety (14 studies, N=1,602 participants) published in the Journal of Ethnopharmacology found that adverse events were mild, transient, and predominantly gastrointestinal (nausea, loose stools) at doses up to 1,250 mg/day [10]. Rare hepatotoxicity cases have been reported in case reports, prompting the FDA MedWatch to receive several spontaneous filings, though a causal mechanism remains unconfirmed [11]. From a cardiovascular standpoint, no serious cardiac adverse events attributable to ashwagandha were documented in any of the 14 trials reviewed.

Dose and Formulation Differences That Matter

Not all ashwagandha products are equal. KSM-66 and Sensoril are the two standardized root extracts with the most RCT data. Over-the-counter products with unstandardized withanolide content may produce different blood pressure and hormonal effects than the trial products. If a patient insists on taking ashwagandha, recommending a standardized extract at the studied dose range (300 to 600 mg/day) rather than a generic root powder gives at least some consistency between what the trial evidence covers and what the patient is actually consuming.

Duration Considerations

Most published trials run 8 to 12 weeks. Long-term effects beyond 12 weeks on blood pressure, cortisol rhythms, or thyroid function are not well characterized in RCT-quality data. Patients planning chronic use should revisit their prescriber every 3 months for a blood pressure review and at least an annual thyroid panel.

Monitoring Protocol if You Are Already Taking Both

If a patient is already combining ashwagandha with lisinopril before speaking to a physician, stopping ashwagandha abruptly is not harmful, because it carries no physiological dependence. The monitoring steps below apply to patients who decide to continue:

1. Baseline blood pressure. Measure at the same time of day, after 5 minutes seated, in both arms at least twice. Record values. The American Heart Association's validated home monitoring guidance recommends calibrated upper-arm cuffs, not wrist devices [12].
2. Day 7 and day 14 checks. If systolic drops more than 15 mmHg from baseline or falls below 100 mmHg, stop ashwagandha and contact the prescribing physician the same day.
3. Baseline labs before starting. BMP (for potassium and creatinine, since lisinopril already stresses these), TSH, free T4, and free T3 if thyroid symptoms are present.
4. 8-week recheck. Repeat TSH and free T4. If TSH has fallen more than 2 mIU/L from baseline, discuss dosing adjustment with the prescriber before continuing.
5. Symptom diary. Note lightheadedness, palpitations, or edema. Palpitations may reflect a thyroid-mediated increase in resting heart rate rather than a cardiac event, but the distinction requires a physician evaluation.

What Lisinopril's Prescribing Information Actually Says About Supplements

The FDA-approved prescribing information for lisinopril (Zestril, Prinivil) specifies drug interactions with potassium supplements, potassium-sparing diuretics, NSAIDs, and antidiabetic agents [8]. It does not specifically mention ashwagandha or herbal adaptogens. This absence does not signal safety. It reflects the regulatory reality that supplement-drug interactions are rarely studied in the key trials required for drug approval. The FDA MedWatch spontaneous reporting system captures some supplement-drug safety signals post-market, but the data are subject to confounding and underreporting [11].

Dr. Pieter Cohen, internist at Harvard Medical School and one of the leading researchers on dietary supplement safety, has noted in published commentary that "the absence of a listed interaction in prescribing information should never be interpreted as evidence of safety for herbal co-administration" [13]. That statement, published in JAMA Internal Medicine, applies directly to the ashwagandha-lisinopril question.

Practical Guidance for Patients

Tell your prescriber before starting ashwagandha. This is not a formality. Given the blood pressure data, the cortisol data, and the thyroid data described above, the prescriber needs this information to interpret your next office blood pressure reading accurately. Ashwagandha's antihypertensive effect could mask inadequate lisinopril dosing or, conversely, produce readings that look well controlled while an occult electrolyte or thyroid problem develops.

If your prescriber says the combination is fine given your specific clinical profile, ask for a written note in your chart and schedule the monitoring labs at 8 weeks. Document your home blood pressure readings in a log you can share at the next visit. The American Heart Association recommends at least 2 readings, taken 1 minute apart, each morning and evening for 1 week before a clinic visit [12]. Following that protocol gives the prescriber actionable data rather than a single in-office snapshot.

The standard starting dose of ashwagandha in clinical trials is 300 mg twice daily of a root extract standardized to at least 5% withanolides. Starting at the lower end (300 mg once daily) and checking blood pressure at 7 days before increasing to twice-daily dosing gives a safer titration window than jumping straight to 600 mg/day, particularly for patients whose systolic is already sitting at or below 125 mmHg on their current lisinopril dose.